false 2025 Q3 --12-31 0001448705 0001448705 2025-01-01 2025-09-30 0001448705 2025-11-25 0001448705 2025-09-30 0001448705 2024-12-31 0001448705 2025-07-01 2025-09-30 0001448705 2024-07-01 2024-09-30 0001448705 2024-01-01 2024-09-30 0001448705 us-gaap:PreferredStockMember 2023-12-31 0001448705 us-gaap:CommonStockMember 2023-12-31 0001448705 us-gaap:AdditionalPaidInCapitalMember 2023-12-31 0001448705 us-gaap:RetainedEarningsMember 2023-12-31 0001448705 2023-12-31 0001448705 us-gaap:PreferredStockMember 2024-03-31 0001448705 us-gaap:CommonStockMember 2024-03-31 0001448705 us-gaap:AdditionalPaidInCapitalMember 2024-03-31 0001448705 us-gaap:RetainedEarningsMember 2024-03-31 0001448705 2024-03-31 0001448705 us-gaap:PreferredStockMember 2024-06-30 0001448705 us-gaap:CommonStockMember 2024-06-30 0001448705 us-gaap:AdditionalPaidInCapitalMember 2024-06-30 0001448705 us-gaap:RetainedEarningsMember 2024-06-30 0001448705 2024-06-30 0001448705 us-gaap:PreferredStockMember 2024-12-31 0001448705 us-gaap:CommonStockMember 2024-12-31 0001448705 us-gaap:AdditionalPaidInCapitalMember 2024-12-31 0001448705 us-gaap:RetainedEarningsMember 2024-12-31 0001448705 us-gaap:PreferredStockMember 2025-03-31 0001448705 us-gaap:CommonStockMember 2025-03-31 0001448705 us-gaap:AdditionalPaidInCapitalMember 2025-03-31 0001448705 us-gaap:RetainedEarningsMember 2025-03-31 0001448705 2025-03-31 0001448705 us-gaap:PreferredStockMember 2025-06-30 0001448705 us-gaap:CommonStockMember 2025-06-30 0001448705 us-gaap:AdditionalPaidInCapitalMember 2025-06-30 0001448705 us-gaap:RetainedEarningsMember 2025-06-30 0001448705 2025-06-30 0001448705 us-gaap:PreferredStockMember 2024-01-01 2024-03-31 0001448705 us-gaap:CommonStockMember 2024-01-01 2024-03-31 0001448705 us-gaap:AdditionalPaidInCapitalMember 2024-01-01 2024-03-31 0001448705 us-gaap:RetainedEarningsMember 2024-01-01 2024-03-31 0001448705 2024-01-01 2024-03-31 0001448705 us-gaap:PreferredStockMember 2024-04-01 2024-06-30 0001448705 us-gaap:CommonStockMember 2024-04-01 2024-06-30 0001448705 us-gaap:AdditionalPaidInCapitalMember 2024-04-01 2024-06-30 0001448705 us-gaap:RetainedEarningsMember 2024-04-01 2024-06-30 0001448705 2024-04-01 2024-06-30 0001448705 us-gaap:PreferredStockMember 2024-07-01 2024-09-30 0001448705 us-gaap:CommonStockMember 2024-07-01 2024-09-30 0001448705 us-gaap:AdditionalPaidInCapitalMember 2024-07-01 2024-09-30 0001448705 us-gaap:RetainedEarningsMember 2024-07-01 2024-09-30 0001448705 us-gaap:PreferredStockMember 2025-01-01 2025-03-31 0001448705 us-gaap:CommonStockMember 2025-01-01 2025-03-31 0001448705 us-gaap:AdditionalPaidInCapitalMember 2025-01-01 2025-03-31 0001448705 us-gaap:RetainedEarningsMember 2025-01-01 2025-03-31 0001448705 2025-01-01 2025-03-31 0001448705 us-gaap:PreferredStockMember 2025-04-01 2025-06-30 0001448705 us-gaap:CommonStockMember 2025-04-01 2025-06-30 0001448705 us-gaap:AdditionalPaidInCapitalMember 2025-04-01 2025-06-30 0001448705 us-gaap:RetainedEarningsMember 2025-04-01 2025-06-30 0001448705 2025-04-01 2025-06-30 0001448705 us-gaap:PreferredStockMember 2025-07-01 2025-09-30 0001448705 us-gaap:CommonStockMember 2025-07-01 2025-09-30 0001448705 us-gaap:AdditionalPaidInCapitalMember 2025-07-01 2025-09-30 0001448705 us-gaap:RetainedEarningsMember 2025-07-01 2025-09-30 0001448705 us-gaap:PreferredStockMember 2024-09-30 0001448705 us-gaap:CommonStockMember 2024-09-30 0001448705 us-gaap:AdditionalPaidInCapitalMember 2024-09-30 0001448705 us-gaap:RetainedEarningsMember 2024-09-30 0001448705 2024-09-30 0001448705 us-gaap:PreferredStockMember 2025-09-30 0001448705 us-gaap:CommonStockMember 2025-09-30 0001448705 us-gaap:AdditionalPaidInCapitalMember 2025-09-30 0001448705 us-gaap:RetainedEarningsMember 2025-09-30 0001448705 2024-01-01 2024-12-31 0001448705 us-gaap:ComputerEquipmentMember 2025-09-30 0001448705 us-gaap:ComputerEquipmentMember 2024-12-31 0001448705 us-gaap:MachineryAndEquipmentMember 2025-09-30 0001448705 us-gaap:MachineryAndEquipmentMember 2024-12-31 0001448705 basa:WebsiteMember 2025-09-30 0001448705 basa:WebsiteMember 2024-12-31 0001448705 us-gaap:StockOptionMember 2025-01-01 2025-09-30 0001448705 us-gaap:StockOptionMember 2024-01-01 2024-12-31 0001448705 us-gaap:WarrantMember 2025-01-01 2025-09-30 0001448705 us-gaap:WarrantMember 2024-01-01 2024-12-31 0001448705 us-gaap:ConvertibleDebtSecuritiesMember 2025-01-01 2025-09-30 0001448705 us-gaap:ConvertibleDebtSecuritiesMember 2024-01-01 2024-12-31 0001448705 2019-03-24 2019-03-25 0001448705 basa:NotesPayableMember 2025-07-01 2025-09-30 0001448705 basa:NotesPayableMember 2025-01-01 2025-09-30 0001448705 basa:NotesPayableMember 2024-07-01 2024-09-30 0001448705 basa:NotesPayableMember 2024-01-01 2024-09-30 0001448705 basa:NotesPayableMember 2025-09-30 0001448705 basa:NotesPayableMember 2024-12-31 0001448705 basa:PromissoryNoteMember 2025-04-03 0001448705 basa:PromissoryNoteMember 2025-04-01 2025-04-03 0001448705 basa:PromissoryNoteMember 2025-05-29 0001448705 basa:PromissoryNoteMember 2025-05-28 2025-05-29 0001448705 basa:PromissoryNoteMember 2025-06-03 0001448705 basa:PromissoryNoteMember 2025-06-01 2025-06-03 0001448705 basa:PromissoryNoteMember 2025-06-04 0001448705 basa:PromissoryNoteMember 2025-06-01 2025-06-04 0001448705 basa:PromissoryNoteMember 2025-06-10 0001448705 basa:PromissoryNoteMember 2025-06-09 2025-06-10 0001448705 basa:PromissoryNoteMember 2025-06-26 0001448705 basa:PromissoryNoteMember 2025-06-25 2025-06-26 0001448705 basa:ConvertibleNotePayableMember 2024-07-01 2024-09-30 0001448705 basa:ConvertibleNotePayableMember 2024-01-01 2024-09-30 0001448705 basa:ConvertibleNotePayableMember 2025-07-01 2025-09-30 0001448705 basa:ConvertibleNotePayableMember 2025-01-01 2025-09-30 0001448705 basa:ConvertibleNotePayableMember 2025-09-30 0001448705 basa:ConvertibleNotePayableMember 2024-12-31 0001448705 2022-03-31 0001448705 basa:FormerChiefExecutiveOfficerMember 2025-07-01 2025-09-30 0001448705 basa:FormerChiefExecutiveOfficerMember 2025-01-01 2025-09-30 0001448705 us-gaap:StockOptionMember 2023-12-31 0001448705 us-gaap:StockOptionMember 2024-01-01 2024-12-31 0001448705 us-gaap:StockOptionMember 2024-12-31 0001448705 us-gaap:StockOptionMember 2025-01-01 2025-09-30 0001448705 us-gaap:StockOptionMember 2025-09-30 0001448705 us-gaap:WarrantMember 2023-12-31 0001448705 us-gaap:WarrantMember 2024-01-01 2024-12-31 0001448705 us-gaap:WarrantMember 2024-12-31 0001448705 us-gaap:WarrantMember 2025-01-01 2025-09-30 0001448705 us-gaap:WarrantMember 2025-09-30 0001448705 us-gaap:WarrantMember basa:ExercisePriceRangeOneMember 2025-01-01 2025-09-30 0001448705 us-gaap:WarrantMember basa:ExercisePriceRangeOneMember 2025-09-30 0001448705 us-gaap:WarrantMember basa:ExercisePriceRangeTwoMember 2025-01-01 2025-09-30 0001448705 us-gaap:WarrantMember basa:ExercisePriceRangeTwoMember 2025-09-30 iso4217:USD xbrli:shares iso4217:USD xbrli:shares xbrli:pure

  

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

———————

FORM 10-Q

———————

 (Mark One)

 

  QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the quarterly period ended: September 30, 2025

 

or

 

¨  TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the transition period from: _____________ to _____________

 

Commission File Number: 000-53574

———————

Basanite, Inc.

(Exact name of registrant as specified in its charter)

———————

Nevada 20-4959207
(State or other jurisdiction (I.R.S. Employer
of incorporation or organization) Identification No.)

 

20 Thompson Road, Unit WH2, Branford, Connecticut 06405

(Address of Principal Executive Office) (Zip Code)

 

(888) 501-1176 

(Registrant’s telephone number, including area code)

 

2660 NW 15th Court, Unit 108

Pompano Beach, FL 33069 

(Former Name, Former Address and Former Fiscal Year, if Changed Since Last Report)

 

———————

Securities registered pursuant to Section 12(b) of the Act: None.

  

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.  Yes   ¨ No

 

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files).   Yes  ¨ No

 

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

 

Large accelerated filer   ¨   Accelerated filer   ¨
Non-accelerated filer        Smaller reporting company  
    Emerging growth company  ¨

 

If an emerging growth company, indicate by checkmark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ¨

 

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). ¨ Yes   No

 

Indicate the number of shares outstanding of each of the issuer’s classes of common stock as of the latest practicable date.

 

Class   Shares Outstanding as of November 25, 2025
Common Stock, $0.001 par value per share   267,560,840

 

 

 

 
 

 

 

 

BASANITE, INC. AND SUBSIDIARIES

TABLE OF CONTENTS

 

    Page No.
  PART I. – FINANCIAL INFORMATION  
     
Item 1. Condensed Consolidated Financial Statements  
  Condensed Consolidated Balance Sheets as of September 30, 2025 (Unaudited) and December 31, 2024 1
  Condensed Consolidated Statements of Operations (Unaudited) for the Three and Nine Months Ended September 30, 2025 and 2024 2
  Condensed Consolidated Statements of Stockholder’s (Deficit) Equity (Unaudited) for Three and Nine Months Ended September 30, 2025 and 2024 3
  Condensed Consolidated Statements of Cash Flows (Unaudited) for the Three and Nine Months Ended September 30, 2025 and 2024 4
  Notes to Condensed Consolidated Financial Statements (Unaudited) 5
     
Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations 15
Item 3. Quantitative and Qualitative Disclosures About Market Risk 19
Item 4. Controls and Procedures 19
     
  PART II. – OTHER INFORMATION  
     
Item 1. Legal Proceedings 20
Item 1A. Risk Factors 20
Item 2. Unregistered Sales of Equity Securities and Use of Proceeds 20
Item 3. Defaults Upon Senior Securities 20
Item 4. Mine Safety Disclosures 20
Item 5. Other Information 20
Item 6. Exhibits  20
Signatures 21

 

 

 i

 
 

  

 

PART I. – FINANCIAL INFORMATION

 

  ITEM 1. FINANCIAL STATEMENTS

 

BASANITE, INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATED BALANCE SHEETS

(UNAUDITED)

   

         
   (Unaudited)     
   September 30, 2025   December 31, 2024 
Assets          
Current assets          
Cash and cash equivalents  $   $82,222 
Accounts receivable   43,349    50,759 
Total current assets   43,349    132,981 
           
Property and equipment, net   81,890    132,728 
Total assets  $125,239   $265,709 
           
Liabilities and Shareholders' Deficit          
 Current liabilities          
Accounts payable  $1,687,615   $1,733,422 
Accruals and other current liabilities   2,820,322    1,815,877 
Note payable - related party   2,683,000    2,653,000 
Convertible debt - related party   2,144,357    2,144,357 
Shareholder loans   475,000    475,000 
Bank indebtedness   88     
Short-term notes payable   270,000    270,000 
Total current liabilities   10,080,382    9,091,656 
           
Total liabilities   10,080,382    9,091,656 
           
Commitments and Contingencies (Note 7)         
           
Shareholders' Deficit          
Preferred stock, $0.001 par value. 5,000,000 authorized, non-issued and outstanding        
Common stock, 1,000,000,000 shares authorized, $0.001 par value, 267,560,840 and 260,157,796 issued and outstanding at September 30, 2025 and December 31, 2024, respectively   267,561    260,157 
Additional paid in capital   49,142,610    48,905,681 
Accumulated deficit   (59,365,314)   (57,991,785)
Total shareholders' deficit   (9,955,143)   (8,825,947)
           
Total liabilities and shareholders' deficit  $125,239   $265,709 

 

The accompanying notes are an integral part of the condensed consolidated financial statements.

 

 

1 
 

 

 

BASANITE, INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

(UNAUDITED) 

 

                 
  

Three Months Ended

September 30, 2025

  

Three Months Ended

September 30, 2024

  

Nine Months Ended

September 30, 2025

  

Nine Months Ended

September 30, 2024

 
Revenues  1,513   $62,836  67,459   $209,176 
Cost of sales   109,878    31,126    148,185    65,579 
Gross profit   (108,365)   31,710    (80,726)   143,597 
                     
Operating expenses                    
General and administrative expenses   175,616    168,857    863,542    508,206 
Total operating expenses   175,616    168,857    863,542    508,206 
                     
Operating loss   (283,981)   (137,147)   (944,268)   (364,609)
                     
Interest expense   (193,700)   (192,930)   (700,404)   (676,607)
Other (income) expense   235,562        235,562    357 
Gain(loss)   35,581    43,915    35,581    (43,915)
Loss before income taxes   (206,538)   (373,992)   (1,373,529)   (1,085,131)
                     
Less Income tax expense                
Net loss  (206,538)   $(373,992)   $(1,373,529)  $(1,085,131)
                     
Weighted average shares   267,560,840    260,156,796    263,194,353    260,156,796 
Earnings per share - basic and diluted  (0.00)  (0.03)  (0.00)  $(0.01)

 

 

The accompanying notes are an integral part of the condensed consolidated financial statements.

 

 

2 
 

 

 

BASANITE, INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY (DEFICIT)

FOR THE THREE & NINE MONTHS ENDED SEPTEMBER 30, 2025, AND 2024

(UNAUDITED)

 

                               
                         
   Preferred Stock   Common Stock   Par Value Common
stock
   Additional Paid in Capital   Accumulated
deficit
   Total 
Balance,  December 31, 2023      259,156,796   $259,157   $48,891,681   $(56,262,389)  $(7,111,551)
Stock issued for services      1,000,000    1,000            1,000 
Net loss               14,000    (287,958)   (273,958)
Balance, March 31, 2024      260,156,796    260,157    48,905,681    (56,550,347)   (7,384,509)
Net loss                  (423,181)   (423,181)
Balance, June 30, 2024      260,156,796    260,157    48,905,681    (56,973,528)   (7,807,690)
Net loss                  (373,992)   (373,992)
Balance, September 30, 2024      260,156,796   $260,157   $48,905,681   $(57,347,520)  $(8,181,682)
                               
                               
Balance, December 31, 2024      260,156,796   $260,157   $48,905,681   $(57,991,785)  $(8,825,947)
Net loss                  (439,195)   (439,195)
Balance, March 31, 2025      260,156,796    260,157    48,905,681    (58,430,980)   (9,265,142)
Stock issued for services      7,404,044    7,404    236,929        244,333 
Net loss                   (727,796)   (727,796)
Balance, June 30, 2025      267,560,840    267,561    49,142,610    (59,158,776)   (9,748,605)
Net loss                  (206,538)   (206,538)
Balance, September 30, 2025      267,560,840   $267,561   $49,142,610   $(59,365,314)  $(9,955,143)

   

 

  

The accompanying notes are an integral part of the condensed consolidated financial statements.

 

 

3 
 

 

 

BASANITE, INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

(UNAUDITED)

 

         
  

Nine Months Ended

September 30, 2025

  

Nine Months Ended

September 30, 2024

 
Cash used in Operating activities          
Net loss  $(1,373,529)  $(1,085,131)
Adjustment to reconcile net loss to net cash used in operating activities:          
Depreciation & amortization   86,418    91,639 
Lease right of use depreciation   56,915    56,915 
Gain on settlement   (35,580)    
Shares issued for services   244,333    15,000 
Changes in operating assets and liabilities:          
Accounts receivable   7,410    690 
Other current assets   (56,915)    
Other current liabilities   483,638    646,880 
Lease liability       (56,915)
Net cash flows from operating activities   (587,310)   (330,922)
           
Investing activities          
Net cash flows from investing activities        
           
Financing activities          
Bank overdrafts   88     
Proceeds from related parties   505,000    278,000 
Net cash flows from financing activities   505,088    278,000 
           
Increase (decrease) in cash during the year   (82,222)   (52,922
Cash, beginning of the period   82,222    55,248 
Cash, end of the period  $   $2,326 
           
Supplemental disclosures          
Cash paid for income taxes  $   $ 
Cash paid for interest  $   $ 

 

  

The accompanying notes are an integral part of the condensed consolidated financial statements.

 

 

4 
 

 

 

BASANITE, INC. AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(UNAUDITED)

 

NOTE 1 – ORGANIZATION, NATURE OF BUSINESS AND GOING CONCERN

 

(A) Description of Business

 

Basanite, Inc., a Nevada corporation (the “Company”, “Basanite”, “we”, “us”, “our” or similar terminology), through our wholly owned subsidiary, Basanite Industries, LLC, a Delaware limited liability company (“BI”), manufactures a range of “green” (environmentally friendly), sustainable, non-corrosive, lightweight, composite products used in concrete reinforcement by the construction industry. Our core product is BasaFlex™, a basalt fiber reinforced polymer reinforcing bar (“rebar”) which we believe is a stronger, lighter, sustainable, non-conductive and corrosion-proof alternative to traditional steel.

 

Our two other main product lines are BasaMix™, which are fine denier basalt fibers available in various sizes, and BasaMesh™, a line of Basalt Geogrid Mesh Rolls, intended to replace welded wire mesh (made of steel) and other fiber reinforced polymer (“FRB”) grids and mesh.

 

BasaMix™ is designed to help absorb the stresses associated with early-aged plastic shrinkage and settlement cracking in concrete, as well as providing an increased toughness for enhanced reinforcement in Slab-on-Grade ("SOG”) and precast elements. BasaMix™ also serves in a “system approach” for optimum performance of a concrete element when used in conjunction with our BasaFlex™ rebar.

 

BasaMesh™ is designed for secondary and temperature shrinkage reinforcement. BasaMesh™ can also work in conjunction with the BasaFlex™ rebar or BasaMix™ for a total reinforcement program.

 

Each of our products is specifically designed to extend the lifecycle of concrete products by eliminating “concrete spalling.” Spalling results from the steel reinforcing materials embedded within the concrete member rusting (contrary to popular belief, concrete is porous and water can permeate into concrete). Rusting leads to the steel expanding and eventually causing the surrounding concrete to delaminate, crack, or even break off, resulting in potential structural failure. We believe that each Basanite product addresses this important need along with other key requirements in today’s construction market.

 

(B) Liquidity and Management Plans

 

Since inception, the Company has incurred net operating losses and used cash in operations. As of September 30, 2025, and December 31, 2024, respectively, the Company reported:

 

  an accumulated deficit of $59.2 million and $58 million;

 

  a working capital deficiency of $9.9 million and $9 million; and

 

  cash used in operations of $112 thousand and $1,056 thousand

  

Losses have principally occurred as a result of the substantial resources required for product research and development and for marketing of the Company’s products; including the general and administrative expenses associated with the organization.

 

While we have generated relatively little revenue to date, revenue from sales of product began to increase in the quarter ended March 31, 2021, and we continue to receive inquiries and solicit orders from a range of customers for our products, indicating what we believe is a significant level of market interest for BasaFlex™. While the Company expects to restart its manufacturing during 2026, based on our current limited manufacturing capacity there is no guarantee that orders will actually be received or that orders, if received, can be properly fulfilled.

 

 

5 
 

 

 

 

NOTE 1 – ORGANIZATION, NATURE OF BUSINESS AND GOING CONCERN (CONTINUED)

 

We have historically satisfied our working capital requirements through the sale of restricted common stock of the Company, $0.001 par value per share (the “Common Stock”), and the issuance of warrants to purchase Common Stock and promissory notes. Until we are able to internally generate meaningful revenue and positive cash flow, we will attempt to fund working capital requirements through third party financing, including through potential private or public offerings of our securities as well as bridge or other loan arrangements. However, a number of factors continue to hinder the Company’s ability to attract new capital investment. We cannot provide any assurances that the required capital will be obtained at all, or that the terms of such required capital may be acceptable to us. If we are unable to obtain adequate financing, we may reduce our operating activities to reduce our cash use until sufficient funding is secured. If we are unable to secure funding when needed, our results of operations may suffer, and our business may fail.

 

These conditions raise substantial doubt about the Company’s ability to continue as a going concern. These condensed consolidated financial statements do not include any adjustments to reflect the possible future effect on the recoverability and classification of assets or the amounts and classifications of liabilities that may result from the outcome of these uncertainties.

 

NOTE 2 – SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

 

(A) Use of Estimates in Financial Statements

 

The presentation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.

 

Stock-based compensation and stock awards related to convertible debt instruments are recognized based on the fair value of the awards granted. The fair value of each award or conversion feature is typically estimated on the grant date using the Black-Scholes pricing model. The Black-Scholes pricing model requires the input of highly subjective assumptions, including the fair value of the underlying Common Stock, the expected term of the option, the expected volatility of the price of our Common Stock, risk-free interest rates and the expected dividend yield of our Common Stock. The assumptions used to determine the fair value of the stock awards represent management’s best estimates. These estimates involve inherent uncertainties and the application of management’s judgment.

 

(B) Principles of Consolidation

 

The condensed consolidated financial statements include the accounts of Basanite, Inc. and its wholly owned subsidiaries, Basanite Industries, LLC and Basalt America, LLC. All intercompany balances have been eliminated in consolidation. The Company’s operations are conducted primarily through Basanite Industries, LLC. Basalt America, LLC is currently inactive.

 

 

6 
 

 

 

 

NOTE 2 – SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (CONTINUED)

 

(C) Cash

 

The Company considers all highly liquid temporary cash instruments with an original maturity of three months or less to be cash equivalents. The Company places its cash, cash equivalents and restricted cash on deposit with financial institutions in the United States, which are insured by the Federal Deposit Insurance Company “("FDIC") up to $250,000. The Company’s credit risk in the event of failure of these financial institutions is represented by the difference between the FDIC limit and the total amounts on deposit. Management monitors the financial institutions credit worthiness in conjunction with balances on deposit to minimize risk. The Company from time to time may have amounts on deposit in excess of the insured limits.

 

(D) Inventories

 

The Company’s inventories consist of raw materials, work in process and finished goods, both purchased and manufactured. Inventories are stated at lower of cost or net realizable value. Cost is determined on the first-in, first-out basis. Raw materials inventory consists of basalt fiber and other necessary elements to produce the basalt rebar. On a quarterly basis, the Company analyzes its inventory levels and records allowances for inventory that has become obsolete and inventory that has a cost basis in excess of the expected net realizable value. The Company had no inventory as of September 30, 2025 and December 31, 2024.

 

(E) Fixed assets

 

Fixed assets consist of the following:

        
   September 30,   December 31, 
   2025   2024 
Computer equipment  $90,502   $89,740 
Machinery   728,245    695,928 
Website   2,500     
    821,247    785,668 
Accumulated depreciation   (739,357)   (652,939)
   $81,890   $132,728 

  

Depreciation expense for the three and nine months ended September 30, 2025, was $28,710 and $89,418 compared to $56,724 and $120,509 for the three and nine months ended September 30, 2024.

 

(F) Deposits and other current assets

 

The Company’s deposits and other current assets consist of the deposits made on equipment, security deposits, utility deposits and other receivables. The deposits are reclassified as part of the fixed asset cost when received and placed into service.

 

(G) Loss Per Share

 

The basic loss per share is calculated by dividing the Company's net loss available to common shareholders by the weighted average number of common shares during the period. The diluted loss per share is calculated by dividing the Company's net loss by the diluted weighted average number of shares outstanding during the period. The diluted weighted average number of shares outstanding is the basic weighted number of shares adjusted for any potentially dilutive debt or equity.

 

The following are potentially dilutive shares not included in the loss per share computation:

         
    September 30,   December 31, 
    2025   2024 
 Options    12,527,778    14,277,778 
 Warrants    114,158,322    121,552,663 
 Convertible securities    8,016,068    8,016,068 
 Total    134,702,168    143,846,509 

 

 

7 
 

 

 

 

NOTE 2 – SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (CONTINUED)

 

(H) Stock-Based Compensation

 

The Company recognizes compensation costs to employees under Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (“ASC”) Topic 718, Compensation – Stock Compensation. Under FASB ASC Topic 718, companies are required to measure the compensation costs of share-based compensation arrangements based on the grant-date fair value and recognize the costs in the financial statements over the period during which employees are required to provide services. Share based compensation arrangements include stock options, restricted share plans, performance-based awards, share appreciation rights and employee share purchase plans. As such, compensation cost is measured on the date of grant at their fair value. Such compensation amounts, if any, are amortized over the respective vesting periods of the grant. The Company recognized $0 in stock-based compensation during the three and nine months ended September 30, 2025.

 

(I) Revenue Recognition

 

We recognize revenue when control of the promised goods or services is transferred to the Company’s customers in an amount that reflects the consideration we expected to be entitled to in exchange for those goods or services. The timing of revenue recognition largely is dependent on shipping terms. Revenue is recorded at the time of shipment for terms designated free on board (“FOB”) shipping point. For sales transactions designated FOB destination, revenue is recorded when the product is delivered to the customer’s delivery site.

 

All revenues recognized are net of trade allowances, cash discounts, and sales returns. Trade allowances are based on the estimated obligations. Adjustments to earnings resulting from revisions to estimates on discounts and returns have been immaterial for each of the reported periods. Shipping and handling amounts billed to a customer as part of a sales transaction are included in revenues, and the related costs are included in cost of goods sold. Shipping and handling is treated as a fulfillment activity, rather than a promised service, and therefore is not considered a separate performance obligation.

 

NOTE 3 – OPERATING LEASE

 

On January 18, 2019, the Company entered into an agreement to lease approximately 25,470 square feet of office and manufacturing space in Pompano Beach, Florida through March 2024. On March 25, 2019, the Company entered into an amendment to the agreement to increase the square footage of leased premises to 36,900 square feet, increasing the Company’s base rent obligation to be approximately $33,825 per month for one year and nine months, and increasing annually at a rate of three percent for the remainder of the lease term.

 

On December 31, 2022 the Company vacated the lease, as of this filing the Company has not entered into a new commercial lease for a manufacturing facility. The Company is actively engaged in a nationwide search to secure a manufacturing facility.

 

On June 1, 2025 the Company entered into in agreement to lease approximately 5,000 square feet of storage space in Branford, Connecticut through May 31, 2026. The Company’s base rent obligation is $3,850 per month for the storage space, based on a month-to-month basis.

 

For the three and nine months ended September 30, 2025, the Company expensed $5,850 and $8,850, compared to $3,000 and $6,000 respectively for rent in 2024.

 

 

8 
 

 

 

 

NOTE 4 – NOTES PAYABLE

 

Notes payable totaled $270,000 for September 30, 2025, and December 31, 2024, respectively.

 

During the three and nine months ended September 30, 2025, the Company made principal payments in the amount of $0 on notes payable.

 

Interest expense for the Company’s notes payable for the three and nine months ended September 30, 2025 was $20,100 and $57,233 compared to $16,200 and $48,600 for the three and nine months ended September 30, 2024.

 

Accrued interest for the Company’s notes payable on September 30, 2025, and December 31, 2024 was $216,864 and $236,963  respectively, and is included in accrued expenses on the accompanying condensed consolidated balance sheets.

 

NOTE 5 – NOTES PAYABLE – RELATED PARTY

 

Notes payable - related party totaled $2,683,000 September 30, 2025 and $2,178,000 December 31, 2024, respectively.

 

On April 3, 2025, the Company issued a promissory note to a board member in exchange for $300,000 bearing an interest rate of 20% per annum and payable on April 2, 2026.

 

On May 29, 2025, the Company issued a promissory note to a board member in exchange for $10,000 bearing an interest rate of 20% per annum and payable on May 28, 2026.

 

On June 3, 2025, the Company issued a promissory note to a board member in exchange for $5,000 bearing an interest rate of 20% per annum and payable on June 2, 2026.

 

On June 4, 2025, the Company issued a promissory note to a board member in exchange for $55,000 bearing an interest rate of 20% per annum and payable on June 5, 2026.

 

 On June 10, 2025, the Company issued a promissory note to a board member in exchange for $10,000 bearing an interest rate of 20% per annum and payable on June 9, 2026.

 

On June 26, 2025, the Company issued a promissory note to a board member in exchange for $125,000 bearing an interest rate of 20% per annum and payable on June 25, 2026.  

 

Interest expense for the Company’s notes payable – related party for the three and nine months ended September 30, 2024 was $109,503 and $297,720, respectively.

 

Interest expense for the Company’s notes payable – related party for the three and Nine months ended September 30, 2025 was $152,133 and $456,400, respectively.

 

Accrued interest for the Company’s notes payable - related party on September 30, 2025, and December 31, 2024, was $1,266,118 and $1,924,705, respectively, and is included in accrued expenses on the accompanying condensed consolidated balance sheets.

 

 

9 
 

 

 

  

NOTE 6 – NOTES PAYABLE – CONVERTIBLE – RELATED PARTY

 

Convertible Notes payable – related party totaled $2,144,357 on September 30, 2025, and December 31, 2024.

 

Interest expense for the Company’s convertible notes payable – related parties for the three and nine months ended September 30, 2024, was $107,218 and $214,436.

 

Interest expense for the Company’s convertible notes payable – related parties for the three and nine months ended September 30, 2025, was $142,957 and 428,872 , respectively.

 

Accrued interest for the Company’s convertible notes payable – related parties on September 30, 2025, and December 31, 2024, was $1,327,373 and $993,434, respectively, and is included in accrued expenses on the condensed consolidated balance sheets.

 

NOTE 7 – SHAREHOLDER LOANS

 

Several officers lend money on an open account. Currently, these short-term loans are converted to notes payable – related party on a regular basis. There is no interest rate indicated on the open accounts. Shareholder loans totaled $475,000 on September 30, 2025 and December 30, 2024.

 

NOTE 8 – COMMITMENTS AND CONTINGENCIES

 

The Company is the obligor under certain promissory notes that are currently past due (although formal events of default have not been declared).

 

See notes 4 and 5.

 

The Company is presently in default of its obligations under the terms of the Company’s private placement which closed in August 2021 to file a registration statement for an underwritten public offering and concurrently listing on a national stock exchange. As a result, the Company is required to pay liquidated damages in the amount of $53,345 per month starting in March 2022, and the maximum amount of such liquidated damages could be approximately $480,000 if such filing is not made.

 

On August 17, 2021, the Company conducted the closing of a private placement offering to accredited investors of the Company’s units at a price of $0.275 per unit, with each unit consisting of: (i) one share of the Company’s common stock, (ii) a five-year, immediately exercisable warrant (“Warrant A”) to purchase one share of common stock at an exercise price of $0.33 per share and (iii) an additional five-year, immediately exercisable warrant to purchase one share of common stock at an exercise price of $0.33 per share (“Warrant B”). The Warrant A and Warrant B are identical, except that the Warrant B has a call feature in favor of the Company, as defined in the offering agreements. In connection with the closing, the Company entered into definitive securities purchase agreements with 19 accredited investors and issued an aggregate of 19,398,144 shares of common stock, Warrant A to purchase up to an aggregate of 19,398,144 shares of common stock, and Warrant B to purchase up to an aggregate of 19,398,144 shares of Common Stock (for an aggregate of 38,796,288 Warrant Shares), for aggregate gross proceeds to the Company of approximately $5,334,490. Costs of the offering in the amount of $611,603 were charged to additional paid in capital. As of December 31, 2022 the Company also accrued the amount of $386,759 as liquidated damages due to the investors in the Company’s August 2021 private placement, such liquidated damages being related to the Company’s failure to timely file a registration statement on Form S-1 for an underwritten public offering and concurrent listing of the Common Stock on a national exchange.

 

 

10 
 

 

NOTE 9 – STOCKHOLDERS’ DEFICIT

 

During the three and nine months ended September 30, 2025, the Company issued 0 and 7,404,044 shares of common stock, respectively, for services.

 

NOTE 10 – OPTIONS AND WARRANTS

 

Stock Options:

 

The following table provides the activity in options for the respective periods:

               
   Total Options
Outstanding
   Weighted Average
Exercise Price
   Aggregate Intrinsic
Value
 
             
Balance at January 1, 2024   1,477,778   $0.05   $ 
Issued       0.05     
Cancelled / Expired   11,550,000    0.05     
                
Balance at December 31, 2024   13,027,778   $0.05   $ 
Exercised       0.05     
Cancelled / Expired   (500,000)   0.05     
Balance at September 30, 2025   12,527,778   $0.05   $ 

 

Options exercisable and outstanding at September 30, 2025 are as follows:

                 
 

Range of

Exercise Prices

   

Number

Outstanding

   

Weighted Average

Remaining

Contractual

Life (Years)

   

Weighted Average

Exercise Price

   

Aggregate

Intrinsic Value

 
                             
  $0.01 - $0.50     12,527,778     4.618     $0.05         

 

See note 8.

 

Stock Warrants:

 

The following table provides the activity in warrants for the respective periods:

             
    Total
Warrants
   Weighted Average
Exercise Price
   Aggregate Intrinsic
Value
 
              
 Balance at January 1, 2024    125,295,757   $0.29   $135,272 
 Granted        0.29     
 Exercised        0.29     
 Cancelled    (3,743,094)        
                  
 Balance at December 31, 2024    121,552,663   $0.29   $135,272 
 Cancelled    (22,605,659)   0.30     
 Balance at September 30, 2025    114,158,322   $0.30   $39,443 

 

 

11 
 

 

 

NOTE 10 – OPTIONS AND WARRANTS (CONTINUED)

 

Warrants exercisable and outstanding at September 30, 2025 are as follows:

                 

Range of

Exercise Prices

 

Number

Outstanding

 

Weighted Average

Remaining

Contractual

Life (Years)

 

Weighted Average

Exercise Price

 

Aggregate

Intrinsic Value

 
                   
  $0.01 - $0.50     114,158,322     1.04   $ 0.30   $ 39,443  
  $0.51 - $1.00            0.85   $ 0.60         
        114,158,322               $ 39,443   

 

NOTE 11 – SUBSEQUENT EVENTS

 

The Company has evaluated all subsequent events through the date these financial statements were issued, and no other subsequent events occurred that required disclosure.

 

Forward-Looking Statements

 

This Current Report on Form 8-K contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements are subject to risks and uncertainties that could cause actual results to differ materially from those expressed in these statements. These risks and uncertainties include, but are not limited to, the ability of the Company to file its Quarterly Report on Form 10-Q in a timely manner, the Company's ability to maintain compliance with OTCQB continued listing standards, and other factors described in the Company's filings with the Securities and Exchange Commission. The Company assumes no obligation to update any forward-looking statements, except as required by law. 

 

 

12 
 

 

 

ITEM 2. MANAGEMENTS DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

  

This overview provides a high-level discussion of our operating results and some of the trends that affect our business. We believe that an understanding of these trends is important to understand our financial results for the three and Nine months ended March 31, 2024 and 2023, respectively. This summary is not intended to be exhaustive, nor is it intended to be a substitute for the detailed discussion and analysis provided elsewhere in this report, and our audited consolidated financial statements and accompanying notes included in the Annual Report in Form 10-K for the period ended December 31, 2024 and filed with the SEC on April 15, 2025.

 

Cautionary Note Regarding Forward-Looking Statements

 

This Quarterly Report on Form 10-Q contains “forward-looking statements” (as defined in Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended). These forward-looking statements are based on our management’s beliefs, assumptions, and expectations and on information currently available to our management. Generally, you can identify forward-looking statements by terms such as “may,” “will,” “should,” “could,” “would,” “expects,” “plans,” “anticipates,” “believes,” “estimates,” “projects,” “predicts,” “potential” and similar expressions intended to identify forward-looking statements, which generally are not historical in nature. All statements that address operating or financial performance, events, or developments that we expect or anticipate will occur in the future are forward-looking statements, including without limitation our expectations with respect to the timing for our planned manufacturing expansion, the benefits of our products, customer leads, product sales, financings, or the commercial viability of, and prospects for, our business model. We may not actually achieve the plans, projections or expectations disclosed in forward-looking statements, and actual results, developments or events (including, without limitation, those related to our planned manufacturing capacity expansion and our sales and marketing initiatives) could differ materially from those disclosed in the forward-looking statements. Our management believes that these forward-looking statements are reasonable as and when made. However, you should not place undue reliance on forward-looking statements because they speak only as of the date when made. We do not assume any obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as may be required by federal securities laws and the rules of the Securities and Exchange Commission (the “SEC”). We may not actually achieve the plans, projections or expectations disclosed in our forward-looking statements, and actual results, developments or events could differ materially and adversely from those disclosed in the forward-looking statements. Forward-looking statements are subject to a number of significant risks and uncertainties, including without limitation those described from time to time in our reports filed with the SEC.

 

The following discussion and analysis of our financial condition and results of operations should be read together with our unaudited interim condensed consolidated financial statements and related notes appearing elsewhere in this Quarterly Report on Form 10-Q as well as the risk factors and other disclosures contained in our Annual Report on Form 10-K for the period ended December 31, 2024.

 

Basanite, Inc., and its wholly owned subsidiaries are referred to in this discussion as the “Company”, “we”, “our”, or “us”. “Common stock” refers to the common stock of the Company.

 

Overview

 

On May 30, 2006, Basanite, Inc. was formed as a Nevada corporation. Through our wholly owned subsidiary, Basanite Industries, LLC, a Delaware limited liability company (“BI”), we manufacture a range of “green” (environmentally friendly), sustainable, non-corrosive, lightweight, composite products used in concrete reinforcement by the construction industry. Our core product is BasaFlex™, a basalt fiber reinforced polymer reinforcing bar (“rebar”) which we believe is a stronger, lighter, sustainable, non-conductive and corrosion-proof alternative to traditional steel.

 

Our two other main product lines are BasaMix™, which are fine denier basalt fibers available in various chopped sizes, and BasaMesh™, a line of Basalt Geogrid Mesh Rolls, intended to replace welded wire mesh (made of steel) and other fiber reinforced polymer grids and mesh.

 

 

13 
 

 

 

BasaMix™ is designed to help absorb the stresses associated with early-aged plastic shrinkage and settlement cracking in concrete, as well as providing an increased toughness for enhanced reinforcement in Slab on Grade (SOG) and precast elements. BasaMix™ also serves in a “system approach” for optimum performance of a concrete element when used in conjunction with our BasaFlex™ rebar.

 

BasaMesh™ is designed for secondary and temperature shrinkage reinforcement. BasaMesh™ can also work in conjunction with the BasaFlex™ rebar or BasaMix™ for a total reinforcement program.

 

Each of our products is specifically designed to extend the lifecycle of concrete products by eliminating “concrete spalling.” Spalling results from the steel reinforcing materials embedded within the concrete member rusting (contrary to popular belief, concrete is porous, and water can permeate into concrete). Rusting leads to the steel expanding and eventually causing the surrounding concrete to delaminate, crack, or even break off, resulting in potential structural failure. We believe that each of our products addresses this important need along with other key requirements in today’s construction market.

 

We believe that the following attributes of BasaFlex™ provide it with a competitive advantage in the marketplace:

 

  BasaFlex™ never corrodes: steel reinforcement products rust, leading to spalling and significant repair costs down the road;

 

  BasaFlex™ is sustainable: BasaFlex™ is made from Basalt rock, the most abundant rock found on Earth’s surface, and offers a longer product lifecycle than traditional steel (the lack of corrosion allows the life span of concrete products reinforced with BasaFlex to be significantly longer);

 

  BasaFlex™ is “green”: From mining, through production, to installation at the building site, BasaFlex™ has an exceptionally low carbon footprint when compared with that of steel; and

 

  BasaFlex™ has a lower in-place cost: the physical nature of our products relative to steel result in a lower net cost to the contractor once installed, such as: BasaFlex™ is one-quarter of the weight of equivalent sized steel, meaning 4 times the quantity of material can be delivered by the same truck (or container); all Basanite products can be loaded/unloaded and moved around the jobsite by hand – no expensive handling equipment is needed; less concrete is required as BasaFlex™ does not require the extra concrete cover needed when using steel; and Basanite products are safer and easier to use. We believe all these factors materially reduce the net in-place cost of concrete reinforcement.

 

We believe that macroeconomic factors are pressuring the construction industry to consider the use of alternative reinforcement materials for the following reasons:

 

  the increasing need for global infrastructure repair;

 

  recent design trends towards increasing the lifespan of projects and materials;

 

  the global interest in promoting the use of sustainable products; and

 

  increasing consideration of both the long-term costs and environmental impacts of material selections.

 

We believe we are well positioned to benefit from this renewed focus, particularly in light of the interest of the U.S. government in funding infrastructure improvements and events such as the collapse of a residential building in Surfside, Florida.

 

Inflation & Interest Rate Sensitivity

 

In the past fiscal years, inflation has not had a significant impact on our business. However, during the second half of 2021, throughout 2022. 2023 and into 2024, the U.S. economy has entered into a period of increasing inflation. Should inflation persist or increase, interest rates rise and could have a significant effect on the economy in general and, thereby, could affect prices for raw materials we use, demand for our products, our ability to attract and retain skilled labor and our future operating results. 

 

14 
 

 

 

Supply Chain

 

In the past year, supply chain shortages or delays have had an immaterial impact on our operations. Our raw material suppliers have maintained a consistent flow of goods which we expect to reengage when manufacturing capabilities are projected to restart in 2026. However, we might experience supply chain challenges in the future, which could harm our business and our results of operations.

 

War in Ukraine

 

The recent war in Ukraine has led the world to issue sanctions on the government of Russia. This has shut down our ability to procure basalt fiber material from our secondary supplier, UWF/Kamenny Vek. However, our primary supplier, Mafic, is U.S. based, and has ample capacity to support our current and anticipated future needs with 100% domestic source of raw materials. We have also recently increased the levels of our safety stock of raw materials as an additional cushion. Nonetheless, we are currently qualifying alternate material from other suppliers to preserve our options in case of further disruptions.

 

Government Approvals and Specifying of our Products

 

We continue to pursue additional product and facility qualifications and approvals, and these qualifications and approvals are critical to the market acceptance of our products. BI is currently testing products at two independent laboratories and received ICC-ES certification, which was granted in the second quarter of 2023, and a Florida Department of Transportation (“FDOT”) production facility and product approval, which was also granted in the second quarter of 2023 (we are already selling to FDOT projects on an individual basis through exemptions or specs). The FDOT approval will allow us to bid on any project approved for BFRP. We anticipate that with these two approvals the prospects of new projects will increase.

 

Results of Operations 

 

Revenue: We had revenue of $1,513 and $67,459 from sales of finished goods for the three and nine months ended September 30, 2025, compared to $288,385 and $434,725 in the prior year. While the decrease in revenue in the year-over-year periods was relatively significant due to our manufacturing constraints and limited working capital.

 

Cost of goods sold: During the three and nine months ended September 30, 2025, we had cost of sales of $109,878 and $148,185 compared to $137,738 and $172,191 in the prior year. We lost money on a gross margin basis due to normal inefficiencies in the start-up and ramping and scaling process, including limited initial sales volume, and further due to extremely narrow margins on the initial sales of our products as we began introducing them to the marketplace as well as paused manufacturing capabilities and relying on outside vendors to assist in fulfillment of goods and services. During the three months ended September 30, 2025, we shipped our excess inventory to a university for testing.

 

Operating Expenses

 

Sales, General, and Administrating Expenses: During the three and Nine months ended September 30, 2025, selling, general, and administrative were $175,616 and $863,542 compared to $360,740 and $1,067,519, respectively in the prior year. The primary components of selling, general, and administrative expenses were as follows:

 

Payroll and related costs: During the three and nine months ended September 30, 2025, payroll and related costs were $118,977 and $148,235, respectively compared to $159,468 and $208,389 in the prior period. The decrease was due to the full reduction of staff in 2024 and 2025 where under advisement of consultants to the Board of the Directors, the Chairman and Chief Executive Officer shuttered all sales and administrative operations for the Company. The Company expects to return to a fully staffed operation by year end 2026.

 

Consulting fees: During the three and nine months ended September 30, 2025, consulting fees were $245,533 and $314,533 compared to $0 and $0 in the prior period, respectively. The Company utilized financial consultants in 2025 in connection with its equity financing, management of the Company and fundraising.

 

Legal fees: During the three and nine months ended September 30, 2025, legal fees were $49,426 and $200,407 compared to $24,800 and $44,059 in the prior period. Legal fees increased primarily due to ongoing matters in the current period.

 

Accounting and audit fees: During the three and nine months ended September 30, 2025, accounting and audit fees were $19,009 and $13,977, respectively, compared to $12,000 and $42,000 in the prior period. Accounting and audit fees consisted of annual audit fees and the cost of outside consultants in the preparation of the Company’s financial statements.

 

 

15 
 

 

 

Liquidity and Capital Resources

 

Since inception, we have incurred net operating losses and negative cash flow. As of September 30, 2025, we had an accumulated deficit of $59,223,377. We have incurred general and administrative expenses associated with our product development and compliance while concurrently setting up our manufacturing facility, beginning operations, and developing our business plan. We also continue to incur legal fees arising from ongoing activities due to fundraising. We expect operating losses to continue in the short term, and we require additional financing for expanding our manufacturing capability and generally scaling our business until we can generate sufficient revenues to achieve positive cash flow. These conditions raise substantial doubt about our ability to continue as a going concern.

 

We have historically satisfied our working capital requirements through the sale of restricted common stock and the issuance of warrants and promissory notes. We will continue our fundraising efforts until we have obtained positive cash flow to cover our expenses. No assurances can be given that we will be successful in raising capital at all or on terms acceptable to us, or at all, and no assurances can be given that even if we raise capital that we will be able to generate sufficient revenue to be cash flow positive.

 

Notwithstanding proceeds from the sale of our securities, a recent related party equipment lease transaction and warrant and option exercises in 2022 and 2023, current working capital is very limited and our projected sales revenue (together with our limited working capital) are presently insufficient to maintain our current operations. In order to grow our manufacturing and sales and marketing operations and reach the level of revenue sufficient to provide positive cash flow, we require significant funding of both our expansion plans (which includes the finalization of our current manufacturing expansion plans and potential investments in other manufacturing facilities, as well as increased headcount necessary to operate our manufacturing at planned capacity) as well as our significant operating deficit while we seeking to scale our manufacturing capability, secure orders from known potential customers and introduce our products to new customers. We will attempt to raise this capital through third party financing, including potential private or public offerings of our securities (including a potential underwritten offering and uplist to a national exchange) as well as bridge or other loan arrangements. However, there is a material risk that we will be unable to secure the required capital (whether through an underwritten uplist financing or otherwise) at all or that the terms of such required financing may be available or acceptable to us. If we are unable to obtain adequate financing, we may reduce our operating activities to reduce our cash use until sufficient funding is secured. If we are unable to secure funding when needed, our results of operations may suffer, and our business may fail.

  

Cash Flows 

 

Net cash used in operating activities amounted to $112,310 for the nine months ended September 30, 2025, compared to $1,055,849 for 2024. The decrease in net cash provided by (used in) operating activities was primarily a result of a decrease in operational activities.

 

During the nine months ended September 30, 2025 and September 30, 2024, we used $0 and $0 net cash for investing activities, respectively.

 

During the nine months ended September 30, 2025 and 2024, net loans from related parties provided $30,000 and 1,080,757, respectively.

 

We do not believe that our cash on hand as of September 30, 2025, will be sufficient to fund our current working capital requirements to the point where we are generating positive cash flow. We have recently entered into several convertible promissory notes to help fund operations and will require additional working capital in the short term. We continue working towards securing more working capital with a preference towards debt which may be convertible to equity. However, there is no assurance that we will be successful in our efforts or, if we are, that the terms will be beneficial to our shareholders.

 

Critical Accounting Estimates

 

The presentation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates. Please see note 2 to the condensed financial statements included in this report. 

 

 

16 
 

 

  

  ITEM 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

 

Not applicable to smaller reporting companies.

 

  ITEM 4. CONTROLS AND PROCEDURES

 

We maintain disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) of the Securities Exchange Act of 1934, as amended (the “Exchange Act”) that are designed to be effective in providing reasonable assurance that information required to be disclosed in our reports under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in the rules and forms of the SEC, and that such information is accumulated and communicated to our management to allow timely decisions regarding required disclosure.

 

Our management, under the supervision and with the participation of our Acting Interim Chief Executive Officer and our Acting Interim Chief Financial Officer, carried out an evaluation of the effectiveness of the design and operation of the Company's disclosure controls and procedures (as defined in Rule 13a-15(e) and 15d-15(e) of the Exchange Act) through September 30, 2025.

 

During our assessment of the effectiveness of internal control as of September 30, 2025, management identified material weaknesses related to (i) the U.S. GAAP expertise and experience of our internal accounting personnel and (ii) a lack of segregation of duties within accounting functions. As a result of these material weaknesses, our management concluded that our internal controls were not effective as of September 30, 2025.

 

We are committed to maintaining a strong internal control environment and implementing measures designed to help ensure that the material weaknesses described above are remediated as soon as possible. We believe we will have the opportunity to remediate these weaknesses when adequate funding is secured. We will consider the material weaknesses remediated after the applicable controls operate for a sufficient period of time, and management has concluded, through testing, that the controls are operating effectively.

 

Because of its inherent limitations, however, readers are cautioned that internal control over financial reporting may not prevent or detect misstatements. Projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies and procedures may deteriorate.

 

Changes in Internal Control over Financial Reporting

 

No change in our system of internal control over financial reporting occurred during the period covered by this report that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.

 

 

17 
 

 

 

PART II. – OTHER INFORMATION

 

  ITEM 1. LEGAL PROCEEDINGS

 

Legal Matters

 

In the ordinary course of operations, the Company may become a party to legal proceedings which could have a material adverse effect on our business, financial condition, cash flows, or results of operations.

 

From time to time, we may become involved in legal proceedings that, individually or in the aggregate, could have a material adverse effect on our business, financial condition, cash flows, or results of operations.

 

As of the date of this report, the Company has filed a lawsuit in the state of Florida against Upstate Custom Products, LLC. The lawsuit is based on the contract entered into by both parties in August 2021 in relation to the manufacturing of the protrusion machines exclusively manufactured by Upstate Custom Products, LLC. As of this filing the lawsuit and claim for relief is ongoing. As of this filing the lawsuit remains ongoing, and more information can be located via the South District of Florida’s website or registration via PACER.

 

On or about October 2023, the Company was served notice of a pending matter of litigation with GS Capital Partners of New York regarding the liquidated damages fees from the 2021 PIPE investment. As of this filing, the matter remains unresolved.

 

Due to our cash flow and liquidity challenges, we have received demand letters from a number of vendors to our company seeking payment of past due amounts to such vendors. As of the date of this report, such demands have not become formal litigations or other proceedings against our company, but they may become litigations against us in the future.

 

Except as set forth above, as of the date of this report, we are not aware of any proceedings pending against our company.

 

  ITEM 1A. RISK FACTORS

 

Not required for smaller reporting companies.

 

  ITEM 2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS

 

None.

 

  ITEM 3. DEFAULTS UPON SENIOR SECURITIES

 

None.

 

  ITEM 4. MINE SAFETY DISCLOSURE

 

Not applicable.

 

  ITEM 5. OTHER INFORMATION

 

Trading Plans

 

During the quarter ended September 30, 2025, no director or Section 16 officer adopted or terminated any Rule 10b5-1 trading arrangements or non-Rule 10b5-1 trading arrangements (in each case, as defined in Item 408(a) of Regulation S-K).

 

  ITEM 6. EXHIBITS

 

Exhibit    
No.   Exhibit Description
31.1   Certification of Chief Executive Officer pursuant to Rule 13A-14(a) or Rule 15d-14(a) of the Securities Exchange Act
31.2   Certification of Chief Financial Officer pursuant to Rule 13A-14(a) or Rule 15d-14(a) of the Securities Exchange Act
32.1   Certification of Chief Executive Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
32.2   Certification of Chief Financial Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
101.INS   Inline XBRL Instance Document (the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document)
101.SCH   Inline XBRL Taxonomy Extension Schema Document
101.CAL   Inline XBRL Taxonomy Extension Calculation Linkbase Document
101.DEF   Inline XBRL Taxonomy Extension Definition Linkbase Document
101.LAB   Inline XBRL Taxonomy Extension Label Linkbase Document
101.PRE   Inline XBRL Taxonomy Extension Presentation Linkbase Document
104   Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101)

 

 

18 
 

 

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

 

Date: November 25, 2025

     
  Basanite, Inc.
     
  By: /s/ Ronald LoRicco, Sr.
    Ronald LoRicco, Sr.
    Acting Interim Chief Executive Officer & Acting Interim Chief Financial Officer
     
     

 

 

19